CDTX
Cidara Therapeutics Inc
NASDAQ: CDTX · HEALTHCARE · BIOTECHNOLOGY
$221.38
+0.00% today
Updated 2026-01-07
Market cap
$6.96B
P/E ratio
—
P/S ratio
4,540.70x
EPS (TTM)
$-11.20
Dividend yield
—
52W range
$15 – $221
Volume
1.5M
Cidara Therapeutics Inc (CDTX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $20.91M | $12.07M | $49.57M | $64.29M | $23.28M | $1.27M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | -42.3% | +310.8% | +29.7% | -63.8% | -94.5% |
| Cost of revenue | — | — | $0.00 | $461000.00 | $732000.00 | $42.82M | $523000.00 | $46.40M | $68.02M | $189000.00 | $143000.00 | $36.76M | $84.88M |
| Gross profit | — | — | $-1.61M | $-461000.00 | $-732000.00 | $-42.82M | $-523000.00 | $-25.49M | $12.07M | $49.57M | $64.29M | $-13.48M | $1.27M |
| Gross margin | — | — | — | — | — | — | — | -121.9% | 100.0% | 100.0% | 100.0% | -57.9% | 100.0% |
| R&D | $12000.00 | $810000.00 | $6.71M | $23.48M | $35.70M | $42.82M | $49.14M | $46.40M | $68.02M | $73.09M | $75.52M | $36.76M | $156.76M |
| SG&A | $780000.00 | $272000.00 | $3.31M | $8.84M | $12.74M | $12.90M | $14.14M | $16.24M | $15.90M | $18.74M | $18.49M | $13.58M | $20.61M |
| Operating income | $-792000.00 | $-1.08M | $-11.62M | $-32.31M | $-48.44M | $-55.72M | $-63.28M | $-41.72M | $-71.85M | $-42.26M | $-29.72M | $-27.06M | $-176.10M |
| Operating margin | — | — | — | — | — | — | — | -199.5% | -595.4% | -85.2% | -46.2% | -116.2% | -13811.9% |
| EBITDA | — | $-1.08M | $-9.84M | $-31.85M | $-47.70M | $-55.05M | $-62.76M | $-41.40M | $-70.80M | $-43.48M | $-28.49M | $-26.95M | $-175.87M |
| EBITDA margin | — | — | — | — | — | — | — | -197.9% | -586.7% | -87.7% | -44.3% | -115.7% | -13793.6% |
| EBIT | $-792000.00 | $-1.08M | $-10.02M | $-32.31M | $-48.44M | $-55.72M | $-63.28M | $-41.72M | $-71.85M | $-42.26M | $-29.72M | $-27.06M | $-176.10M |
| Interest expense | — | $0.00 | $0.00 | $120000.00 | $271000.00 | $7000.00 | $629000.00 | $221000.00 | $262000.00 | $212000.00 | $191000.00 | — | — |
| Income tax | — | $-987000.00 | $1.70M | $-461000.00 | $-732000.00 | $-667000.00 | $4.27M | $-1.01M | $262000.00 | $1.44M | $272000.00 | $15000.00 | — |
| Effective tax rate | 0.0% | 42.3% | -16.6% | 1.4% | 1.5% | 1.2% | -7.8% | 2.4% | -0.4% | -3.4% | -0.9% | -0.1% | 0.0% |
| Net income | $-792000.00 | $-1.34M | $-11.89M | $-32.19M | $-48.16M | $-55.73M | $-59.02M | $-41.09M | $-72.11M | $-43.91M | $-29.80M | $-22.93M | $-169.83M |
| Net income growth (YoY) | — | -69.7% | -785.0% | -170.7% | -49.6% | -15.7% | -5.9% | +30.4% | -75.5% | +39.1% | +32.1% | +23.0% | -640.6% |
| Profit margin | — | — | — | — | — | — | — | -196.5% | -597.6% | -88.6% | -46.4% | -98.5% | -13319.8% |